Medical Disclaimer: We are not doctors, pharmacists, or medical professionals, and nothing in this comparison is medical advice. This is independent editorial content for informational purposes only. GLP-1 medications are prescription-only — a licensed clinician determines eligibility and treatment. Compounded medications are not FDA-approved. Individual results vary, and weight loss is never guaranteed.
Affiliate Disclosure: Some links on this page may earn us a commission at no extra cost to you. Commissions never influence a ranking or verdict. We are not affiliated with or endorsed by either company; all trademarks belong to their owners.
Not everyone shopping for a GLP-1 telehealth program wants the biggest brand — many people just want the lowest workable monthly number with legitimate medical oversight. That’s the lane Wellorithm and AltRx compete in, and they take different approaches to it. Here’s how they stack up on the criteria that decide whether a budget program is actually a good deal.
Round 1: Published pricing
Wellorithm publishes among the lowest starting prices in the market: compounded semaglutide from $147 and compounded tirzepatide from $249. One structural detail matters, though: membership is billed on a recurring 28-day cycle, which works out to 13 payments a year rather than 12 — so the true annual cost runs about 8% above the naive monthly math. AltRx emphasizes transparent plan pricing across compounded GLP-1 and GLP-1/GIP options, with flexible payment options, but its headline numbers vary by plan and current promotions. On raw published entry price, Wellorithm takes it — with the 28-day asterisk firmly attached. Winner: Wellorithm.
Round 2: Medication lineup
Wellorithm’s program centers on two compounded options: semaglutide and tirzepatide, prepared by partner U.S. compounding pharmacies. AltRx offers compounded GLP-1 and GLP-1/GIP treatments plus access to branded medications such as Ozempic and Mounjaro when a clinician deems them appropriate — more flexibility if a provider steers you toward a brand-name product. Both platforms state plainly that compounded medications are not FDA-approved, which is exactly the transparency you should demand. Winner: AltRx.
Round 3: Guarantees and refund terms
This round is where reading the fine print pays for itself. Wellorithm publishes a performance-based guarantee: per its terms, patients who don’t lose at least 10% of baseline weight after 16 weeks of adherent use may be eligible for a refund of up to four months of fees — with verification requirements that can include a doctor’s attestation or a recorded weigh-in. Meanwhile, its standard payments are described as non-refundable once processed. AltRx’s key fine print is different: your payment method may be pre-authorized before final approval, so understanding what happens if you’re not approved, offered an alternative, or want to cancel is essential before checkout. Neither policy is a dealbreaker; both demand that you read the terms rather than the headline. Winner: Wellorithm, for having a published performance guarantee at all.
Round 4: Care experience
Wellorithm advertises 24/7 support and pairs patients with clinicians it describes as board-certified specialists; its Trustpilot profile (a modest but growing review base, around a 4-star average) includes recurring praise for responsive staff and providers who set practical targets like protein goals — along with some complaints that recurring prices after the first month weren’t communicated prominently enough. AltRx bundles virtual consultations, prescription processing, shipping, and customer support into its care model, though third-party reviewers note support responsiveness can be inconsistent. Winner: Wellorithm, narrowly.
The verdict
Choose Wellorithm if the entry price is your deciding factor and a published performance guarantee gives you confidence — just budget for 13 four-week cycles a year and screenshot the guarantee terms on day one. Choose AltRx if you want a budget platform that can also route you to branded Ozempic or Mounjaro if your clinician recommends it, and you’re diligent about reading pre-authorization and cancellation terms before entering a card.
Who should skip both: anyone who wants an FDA-approved product shipped by the platform itself (see Brightmeds in our TrimRX vs. Brightmeds face-off), anyone with insurance coverage that beats cash pricing, and anyone who hasn’t first had a licensed clinician confirm GLP-1 treatment makes sense for their health picture. Compare all four providers in our head-to-head roundup.